CTA
INSM icon

Carillon Tower Advisers’s Insmed INSM Stock Holding History

Carillon Tower Advisers’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$35.8M Sell
1,074,867
-89,200
-8% -$3.26M 0.22% 143
2020
Q3 		$37.4M Sell
1,164,067
-23,834
-2% -$685K 0.5% 40
2020
Q2 		$32.7M Buy
1,187,901
+61,200
+5% +$1.45M 0.25% 125
2020
Q1 		$16.1M Buy
1,126,701
+80,400
+8% +$1.91M 0.16% 204
2019
Q4 		$25M Hold
1,046,301
– – 0.17% 214
2019
Q3 		$18.5M Hold
1,046,301
– – 0.13% 260
2019
Q2 		$26.8M Buy
+1,046,301
New +$29.1M 0.18% 206

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Carillon Tower Advisers's INSM Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Insmed (INSM) stake by 7.7% in Q4 2020, selling an estimated $3.26M and leaving 1,074,867 shares worth $35.8M. The position accounts for 0.22% of the portfolio, ranked #143.

Carillon Tower Advisers first reported a position in INSM in Q2 2019 and has held it in 7 quarters since. The position peaked at $37.4M in Q3 2020. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

  • Carillon Tower Advisers held 1,074,867 shares of Insmed worth $35.8M as of Q4 2020.
  • Carillon Tower Advisers sold 89,200 Insmed shares in Q4 2020, an estimated $3.26M.
  • Insmed made up 0.22% of Carillon Tower Advisers's portfolio in Q4 2020, its #143 holding.
  • Carillon Tower Advisers first reported a position in Insmed in Q2 2019 and has held it in 7 quarters since.
  • Carillon Tower Advisers's Insmed position peaked at $37.4M in Q3 2020.
  • 206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.